Clinical Trial Update: Brexpiprazole as an Adjunctive Treatment to Paroxetine or Sertraline in Adult Patients Suffering From Post-traumatic Stress Disorder (PTSD) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating brexpiprazole as an adjunct to paroxetine or sertraline for adults with post-traumatic stress disorder was terminated, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• brexpiprazole (brexpiprazole)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Post-traumatic Stress Disorder, PTSD | Phase 3 | Status: TERMINATED | Results posted: 2017-03-13